Results

Total Results: 2,279 records

Showing results for "factor".

  1. effectivehealthcare-admin.ahrq.gov/products/stroke-atrial-fibrillation/research
    December 01, 2019 - antithrombotic strategies, devices, and oral anticoagulants, including oral direct thrombin inhibitors and factor … We found that a factor IIa inhibitor (dabigatran 150 mg) was superior to warfarin in reducing the incidence
  2. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
    December 01, 2009 - intended to evaluate the accuracy of different methods of performing breast biopsy and to explore what factor … factors on accuracy and harms Strength of evidence Impact on Impact on supporting the Category Factor … improves Insufficient data Insufficient experience with experience Insufficient data for any other factor … category Factor Level of evidence factor on accuracy Patient characteristics Patient age Insufficient … on Factor category Factor Level of evidence harms Patient characteristics Patient age Insufficient
  3. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
    February 17, 2016 - There were few studies evaluating the new factor Xa inhibitors. … or treatment durations of the same thromboprophylaxis interventions (low molecular weight heparin, factor … All KQ o   Injectable unfractionated heparin KQ 1, 4 (in combination), 5, 6 o   Injectable or oral factor …  for  postthrombotic   syndrome  and  proximal  DVTs  are  believed  to  be  a  higher  risk  factor … 1) comparisons of classes of thromboprophylaxis interventions (e.g., low molecular weight heparin, factor
  4. effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases?page=0
    November 01, 2024 - Report Systematic Review Archived March 7, 2012 Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010 Antinuclear Antibody, Rheumatoid Factor
  5. effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases
    November 01, 2024 - Report Systematic Review Archived March 7, 2012 Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010 Antinuclear Antibody, Rheumatoid Factor
  6. 04-E029-1 Summary (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Behavioral indications No cohort used this factor. … Gleason score No cohort used this factor. … Behavioral indications No cohort explicitly used this factor. … Availability of technology No study addressed this factor. … Small area variation No study addressed this factor.
  7. effectivehealthcare-admin.ahrq.gov/health-topics/arthritis?page=0
    November 14, 2023 - Update Systematic Review Archived March 7, 2012 Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010 Antinuclear Antibody, Rheumatoid Factor
  8. effectivehealthcare-admin.ahrq.gov/health-topics/arthritis
    November 14, 2023 - Update Systematic Review Archived March 7, 2012 Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010 Antinuclear Antibody, Rheumatoid Factor
  9. effectivehealthcare-admin.ahrq.gov/health-topics/connective-tissue-disorders
    May 24, 2017 - Report Systematic Review Archived March 7, 2012 Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010 Antinuclear Antibody, Rheumatoid Factor
  10. effectivehealthcare-admin.ahrq.gov/products/autoimmune-disease/rapid-research
    October 01, 2024 - There is weak evidence for lowering of other inflammatory markers like Tumor necrosis factor alpha (TNFα … weak evidence for other outcomes like anti-citrullinated protein autoantibodies (ACPAs), rheumatoid factor
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
    August 22, 2012 - Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal … situ and early invasive breast cancer Breast Cancer Diagnostic Workup Data Points # 15 Prognostic factor … Current guidelines do not recommend routine testing for human epidermal growth factor receptor 2 (HER2 … Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast … ER = estrogen receptor, PR = progesterone receptor, HER2 = human epidermal growth factor receptor-2.
  12. effectivehealthcare-admin.ahrq.gov/health-topics/health-facilities?page=4
    July 12, 2011 - October 29, 2010 Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor … Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
    March 01, 2012 - 1 Comparative Effectiveness Review Number 50 Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated … Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children. … Rheumatoid factor in children with lupus erythematosus. A serologic study. … Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. … factor in juvenile chronic arthritis.
  14. effectivehealthcare-admin.ahrq.gov/products/antidepressants-seniors-pneumonia/research
    January 01, 2020 - One major etiologic factor for pneumonia in the elderly is aspiration of oropharyngeal contents [ 3 , … We then examined each potential confounding factor individually using a change-in-estimate criterion … In particular, we individually added each potential confounding factor to the minimally adjusted model … If any factor changed the OR of interest by ten percent or more, we considered it to be a confounding … factor and retained it in the "change-in-estimate" adjusted model.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
    February 01, 2018 - For example, recommend against selecting fixed effects model because P>0.1 ► Such approaches do not factor … large effect sizes, or more frequent outcomes (5-10%), the Mantel-Haenszel method (without correction factor … consider the Peto method, the Mantel-Haenszel method, or logistic regression without correction factor … method, the Mantel- Haenszel method, or a logistic regression approach, without adding a correction factor
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
    March 27, 2014 - g Categories of JIA include: • Systemic arthritis • Oligoarthritis • Rheumatoid-factor positive ( … RF+) polyarthritis • Rheumatoid-factor negative (RF-) polyarthritis • Enthesitis-related arthritis
  17. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
    September 01, 2011 - Comparative Effectiveness Review Number 28 Effective Health Care 2 • Rheumatoid-factor positive … • Rheumatoid-factor negative (RF-) polyarthritis: Affects five or more joints during the first 6 months … (FDA) recently placed a box warning on the entire class of biologic DMARDs targeting tumor necrosis factor … (g) Categories of JIA include: • Systemic arthritis • Oligoarthritis • Rheumatoid-factor positive … (RF+) Polyarthritis • Rheumatoid-factor negative (RF-) polyarthritis • Enthesitis-related arthritis
  18. effectivehealthcare-admin.ahrq.gov/health-topics/dietary-proteins?page=3
    August 29, 2011 - October 29, 2010 Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor … Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor
  19. effectivehealthcare-admin.ahrq.gov/health-topics/throat-cancer
    For example, having HPV is a risk factor for oropharyngeal cancer.
  20. effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018
    October 01, 2019 - Two-agent treatments with MTX and tumor necrosis factor (TNF) biologics or non-TNF biologics most likely … Combination therapy with TNF (tumor necrosis factor) or non-TNF biologics plus MTX improved disease control

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: